Study Summary
This trialtests a new drug to find the safest dose for cancer patients.
- Advanced Solid Tumors
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 24 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
STP1002
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: STP1002 · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there still room for potential participants in this research project?
"According to clinicaltrials.gov, this medical trial is open for recruitment and was initially posted on July 30th 2020 with a most recent update occurring almost exactly one year later on September 25th 2021." - Anonymous Online Contributor
Has the FDA sanctioned STP1002 for therapeutic purposes?
"Due to the preliminary nature of this experiment, our team at Power has conservatively rated STP1002's safety with a score of 1. This is because Phase 1 trials only provide limited insight into efficacy and safety." - Anonymous Online Contributor
To what extent is the current clinical trial garnering participation?
"Affirmative. According to clinicaltrials.gov, this research endeavour was first posted on July 30th of 2020 and has been actively enrolling participants since then; the last edit took place on September 25th 2021. Altogether, it is hoped that 30 patients will be recruited from 3 distinct medical centres throughout its duration." - Anonymous Online Contributor